March 2, 2021- Frederick, MD – Effective March 1st, 2021 the Oregon Health Authority has completed “Phase 3 Rulemaking” of the Toxic-Free Kids Act, a law requiring manufacturers of children’s products sold on Oregon to report and ultimately remove certain high priority chemicals of concern for
February 16, 2021- Frederick, MD – A2LA is pleased to announce the accreditation of Cannalytics, LLC to ISO/IEC 17025:2017 for cannabis testing. Cannalytics, based in San Juan, Puerto, was accredited by A2LA in December 2020 and is the first cannabis testing laboratory accredited in Puerto Rico.
January 28, 2021, Frederick, MD – A2LA members have elected and approved two new individuals to A2LA’s Board of Directors for terms beginning January 1, 2021. Mike Carter, CEO of Western Energy Support and Technology (WEST), is an accomplished executive with over 29 years of experience in flow
Colorado was among the first states to legalize cannabis products for medical use and the second state to legalize recreational cannabis use for adult use. As a result, Colorado has one of the best-established cannabis infrastructures in the US and boasts many highly trusted cannabis testing
Across every industry and every profession, 2020 has been a year of seismic change and challenging paradigm shifts. Yet amidst the stress of this pandemic there have also been opportunities for problem-solving, innovation, and collaboration. A2LA has needed to dramatically re-imagine the assessment
In a sweeping show of popular support, New Jersey, Arizona, Montana, and South Dakota have all voted to legalize the recreational use of marijuana, and Mississippi has voted to legalize marijuana for medical use. In all five states, the decision was made by ballot measure. These five states are only
A2LA is proud to announce that it has been granted ASCA (Accreditation Scheme for Conformity Assessment) Recognition by the FDA, making it among the first accreditation bodies accepted as a participant in the ASCA Pilot program. The ASCA Pilot is a cooperative program that relies on participation
As more and more states across America legalize cannabis, it is important to ensure that the public can be confident in the end product that they use. A2LA is engaged in ensuring quality and compliance in this industry, as evidenced by our ever-growing presence in industry groups, influence on state